TRAM Snapshot of App at Pub for Oppostn

ZARXIO

Novartis AG

TRAM Snapshot of App at Pub for Oppostn

Trademark Snap Shot Publication Stylesheet (Table presents the data on Publication Approval)
OVERVIEW
SERIAL NUMBER	86242357	FILING DATE	04/04/2014
REG NUMBER	0000000	REG DATE	N/A
REGISTER	PRINCIPAL	MARK TYPE	TRADEMARK
INTL REG #	N/A	INTL REG DATE	N/A
TM ATTORNEY	WANG, WEN HSING	L.O. ASSIGNED	108

PUB INFORMATION
RUN DATE	12/08/2015
PUB DATE	11/04/2014
STATUS	819-SU - REGISTRATION REVIEW COMPLETE
STATUS DATE	12/07/2015
LITERAL MARK ELEMENT	ZARXIO

DATE ABANDONED	N/A	DATE CANCELLED	N/A
SECTION 2F	NO	SECTION 2F IN PART	NO
SECTION 8	NO	SECTION 8 IN PART	NO
SECTION 15	NO	REPUB 12C	N/A
RENEWAL FILED	NO	RENEWAL DATE	N/A
DATE AMEND REG	N/A

FILING BASIS
FILED BASIS		CURRENT BASIS		AMENDED BASIS
1 (a)	NO	1 (a)	YES	1 (a)	NO
1 (b)	YES	1 (b)	NO	1 (b)	NO
44D	NO	44D	NO	44D	NO
44E	NO	44E	NO	44E	NO
66A	NO	66A	NO
NO BASIS	NO	NO BASIS	NO

MARK DATA
STANDARD CHARACTER MARK	NO
LITERAL MARK ELEMENT	ZARXIO
MARK DRAWING CODE	3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S)
COLOR DRAWING FLAG	YES

CURRENT OWNER INFORMATION
PARTY TYPE	20-OWNER AT PUBLICATION
NAME	Novartis AG
ADDRESS	CH-4002 Basel,
ENTITY	03-CORPORATION
CITIZENSHIP	Switzerland

GOODS AND SERVICES
INTERNATIONAL CLASS	005
DESCRIPTION TEXT	Pharmaceutical preparations for use in stimulating white blood cell production available only by prescription

GOODS AND SERVICES CLASSIFICATION
INTERNATIONAL CLASS	005	FIRST USE DATE	09/03/2015	FIRST USE IN COMMERCE DATE	09/03/2015	CLASS STATUS	6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS
CHANGE IN REGISTRATION	NO
COLORS CLAIMED STATEMENT	The color(s) blue, light gray, dark gray and white is/are claimed as a feature of the mark.
DESCRIPTION OF MARK	The mark consists of three overlapping small, medium and large teardrops followed by the word ZARXIO.

PROSECUTION HISTORY
DATE	ENT CD	ENT TYPE	DESCRIPTION	ENT NUM
12/08/2015	SUNA	E	NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED	045
12/07/2015	CNPR	P	ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED	044
12/04/2015	TEME	I	TEAS/EMAIL CORRESPONDENCE ENTERED	043
12/04/2015	CRFA	I	CORRESPONDENCE RECEIVED IN LAW OFFICE	042
12/04/2015	TROA	I	TEAS RESPONSE TO OFFICE ACTION RECEIVED	041
09/21/2015	GNRN	O	NOTIFICATION OF NON-FINAL ACTION E-MAILED	040
09/21/2015	GNRT	O	NON-FINAL ACTION E-MAILED	039
09/21/2015	CNRT	W	SU - NON-FINAL ACTION - WRITTEN	038
09/12/2015	SUPC	I	STATEMENT OF USE PROCESSING COMPLETE	037
09/03/2015	IUAF	S	USE AMENDMENT FILED	036
09/12/2015	AITU	A	CASE ASSIGNED TO INTENT TO USE PARALEGAL	035
09/03/2015	EISU	I	TEAS STATEMENT OF USE RECEIVED	034
06/23/2015	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	033
06/20/2015	EX1G	S	EXTENSION 1 GRANTED	032
06/20/2015	EXT1	S	EXTENSION 1 FILED	031
06/20/2015	EEXT	I	TEAS EXTENSION RECEIVED	030
12/30/2014	NOAM	E	NOA E-MAILED - SOU REQUIRED FROM APPLICANT	029
11/04/2014	NPUB	E	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	028
11/04/2014	PUBO	A	PUBLISHED FOR OPPOSITION	027
10/15/2014	NONP	E	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	026
09/30/2014	PREV	O	LAW OFFICE PUBLICATION REVIEW COMPLETED	025
09/26/2014	CNSA	P	APPROVED FOR PUB - PRINCIPAL REGISTER	024
09/25/2014	XAEC	I	EXAMINER'S AMENDMENT ENTERED	023
09/25/2014	GNEN	O	NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	022
09/25/2014	GNEA	O	EXAMINERS AMENDMENT E-MAILED	021
09/25/2014	CNEA	R	EXAMINERS AMENDMENT -WRITTEN	020
09/16/2014	TEME	I	TEAS/EMAIL CORRESPONDENCE ENTERED	019
09/15/2014	CRFA	I	CORRESPONDENCE RECEIVED IN LAW OFFICE	018
09/15/2014	TROA	I	TEAS RESPONSE TO OFFICE ACTION RECEIVED	017
09/05/2014	GNRN	O	NOTIFICATION OF NON-FINAL ACTION E-MAILED	016
09/05/2014	GNRT	O	NON-FINAL ACTION E-MAILED	015
09/05/2014	CNRT	R	NON-FINAL ACTION WRITTEN	014
08/22/2014	ZZZX	Z	PREVIOUS ALLOWANCE COUNT WITHDRAWN	013
08/12/2014	PBCR	Z	WITHDRAWN FROM PUB - OG REVIEW QUERY	012
07/31/2014	PREV	O	LAW OFFICE PUBLICATION REVIEW COMPLETED	011
07/28/2014	ALIE	A	ASSIGNED TO LIE	010
07/15/2014	CNSA	P	APPROVED FOR PUB - PRINCIPAL REGISTER	009
06/24/2014	XAEC	I	EXAMINER'S AMENDMENT ENTERED	008
06/24/2014	GNEN	O	NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	007
06/24/2014	GNEA	F	EXAMINERS AMENDMENT E-MAILED	006
06/24/2014	CNEA	R	EXAMINERS AMENDMENT -WRITTEN	005
06/16/2014	DOCK	D	ASSIGNED TO EXAMINER	004
04/18/2014	MDSC	E	NOTICE OF DESIGN SEARCH CODE E-MAILED	003
04/17/2014	NWOS	I	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	002
04/08/2014	NWAP	I	NEW APPLICATION ENTERED IN TRAM	001

CURRENT CORRESPONDENCE INFORMATION
ATTORNEY	Maury M. Tepper, III
CORRESPONDENCE ADDRESS	MAURY M. TEPPER, III TEPPER & EYSTER, PLLC 3724 BENSON DR RALEIGH, NC 27609-7321
DOMESTIC REPRESENTATIVE	Novartis Pharmaceuticals Corporation

PRIOR OWNER INFORMATION
PARTY TYPE	10-ORIGINAL APPLICANT
NAME	Novartis AG
ADDRESS	CH-4002 Basel,
ENTITY	03-CORPORATION
CITIZENSHIP	Switzerland

TRAM Snapshot of App at Pub for Oppostn [image/jpeg]

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.